1. Home
  2. PDFS vs OGN Comparison

PDFS vs OGN Comparison

Compare PDFS & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$44.13

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.69

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
OGN
Founded
1992
1923
Country
United States
United States
Employees
600
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
PDFS
OGN
Price
$44.13
$13.69
Analyst Decision
Strong Buy
Hold
Analyst Count
3
5
Target Price
$39.67
$11.40
AVG Volume (30 Days)
604.4K
2.9M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
0.60%
EPS Growth
N/A
N/A
EPS
0.22
0.95
Revenue
N/A
$6,216,000,000.00
Revenue This Year
$22.13
$0.45
Revenue Next Year
$18.92
$1.67
P/E Ratio
$198.77
$14.41
Revenue Growth
N/A
N/A
52 Week Low
$21.96
$5.69
52 Week High
$71.69
$13.79

Technical Indicators

Market Signals
Indicator
PDFS
OGN
Relative Strength Index (RSI) 45.29 50.97
Support Level $43.00 $13.46
Resistance Level $50.62 $13.79
Average True Range (ATR) 2.16 0.04
MACD 0.02 -0.01
Stochastic Oscillator 38.69 35.48

Price Performance

Historical Comparison
PDFS
OGN

About PDFS PDF Solutions Inc.

PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

Share on Social Networks: